Integra LifeSciences Corporation
Clinical trials sponsored by Integra LifeSciences Corporation, explained in plain language.
A medical technology company focused on surgical instruments and neurosurgical products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New dressings aim to close stubborn wounds faster Results expected Dec 2026 (estimated)
-
New device aims to gently suck out brain clots without major surgery
Disease control Recruiting nowThis registry tracks 500 adults with a large brain bleed who undergo a minimally invasive procedure using the Aurora Surgiscope. The device helps surgeons see and remove the clot through a small opening. The main goal is to see if the procedure can reduce the clot to less than 15…
Sponsor: Integra LifeSciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New registry to monitor balloon procedure for Children's ear troubles
Knowledge-focused Recruiting nowThis study is a registry that will follow 300 children under 18 who receive a balloon dilation treatment for Eustachian tube dysfunction. Researchers will track how often the procedure fails and needs repeat surgery. The goal is to confirm the device's real-world performance in k…
Sponsor: Integra LifeSciences Corporation • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC